Towards a Molecular Classification of Pulmonary Sarcomatoid Carcinomas

Affiliations

¹ Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: mansfield.aaron@mayo.edu.
² Department of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
³ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

Free article

Editorial

Aaron S Mansfield et al. J Thorac Oncol. 2017 Jun.

Free article

. 2017 Jun;12(6):910-912.

doi: 10.1016/j.jtho.2017.04.012.

¹ Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: mansfield.aaron@mayo.edu.
² Department of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
³ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

No abstract available

Comment on

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Schrock AB, Li SD, Frampton GM, Suh J, Braun E, Mehra R, Buck SC, Bufill JA, Peled N, Karim NA, Hsieh KC, Doria M, Knost J, Chen R, Ou SI, Ross JS, Stephens PJ, Fishkin P, Miller VA, Ali SM, Halmos B, Liu JJ. Schrock AB, et al. J Thorac Oncol. 2017 Jun;12(6):932-942. doi: 10.1016/j.jtho.2017.03.005. Epub 2017 Mar 16. J Thorac Oncol. 2017. PMID: 28315738